Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

(Photo:Cory Clark/NurPhoto)

Medical marijuana's potential as an alternative to dangerous, addictive prescription painkillers is earning is a closer look in Washington.

Between the lines: Most states allow medical uses of marijuana, but Attorney General Jeff Sessions has taken a hardline stance on marijuana prosecution. That conflict has heightened Congress' attention to the issue, and lawmakers are increasingly on the states' side.

Why it matters: Advocates say medical marijuana has several uses — including, as an alternative to opioid painkillers.

  • One study published in Journal of the American Medical Association found that states with medical marijuana laws had lower opioid overdose death rates.
  • "Opioids are a big, popular topic in statehouses nowadays. It’s just not there at the federal level because... [the administration is] just not willing to acknowledge that cannabis can be part of health care," said Jeremy Unruh, director of regulatory affairs of PharmaCann, a medical marijuana company.

The catch: There are more barriers to medical marijuana than opioid painkillers, even though opioids are at the center of the country's more pressing public health crisis.

  • "To me, it’s illogical to say, ‘We’re perfectly OK with having opioids prescribed, highly addictive opioids, but not look at cannabinoids," said Sen. Thom Tillis. "It just doesn’t make sense to me from a scientific perspective.”

Where it stands: The tension between state laws permitting medical marijuana and federal law classifying it as an illegal narcotic came to a head when Sessions released a memo directing U.S. attorneys to enforce federal law.

Congress has been working on legislation that would protect state law.

  • House and Senate committees have both passed measures designed to stop federal officials from standing in the way of states implementing their own own laws — which has become routine.
  • Sens. Cory Gardner and Elizabeth Warren recently introduced a bill that would essentially make federal law respect states' marijuana laws.
  • "Certainly there’s been a lot of preliminary research that shows it can be an alternative. And that’s one of the areas I’d like to see more research focused," Gardner said.

The problem: Marijuana's federal status as an illegal drug makes research into its medical benefits difficult.

  • There's still a stigma around marijuana, especially for older lawmakers.
  • Gardner says the lawmakers sponsoring his bill aren't "some of the people who have been here for the longest time," adding that, "This is a big educational process. We’re going to have to get more people up to speed on how this is going to work, what it means, what the industry is, what it’s not.”

Go deeper

Ben Geman, author of Generate
55 mins ago - Energy & Environment

The road to COP26 gets slightly easier

Illustration: Annelise Capossela/Axios

The bad diplomatic vibes heading into the critical United Nations climate summit in Glasgow, Scotland, might be improving slightly.

Catch up fast: Chinese President Xi Jinping yesterday pledged to end overseas finance for building new coal-fired power plants and boost support for clean energy in developing nations.

Narrowing the employee divide

Illustration: Shoshana Gordon/Axios

Companies are narrowing the blue- and white-collar experience as they're forced to adapt to a worker-led market.

Driving the news: Basic office tools and concepts like corporate communications and schedule flexibility are migrating to frontline operations through investments in technology.

3 hours ago - Health

U.S. to buy 500 million more Pfizer doses to share with the world

A nurse fills a syringe with a dose of the Pfizer-BioNTech COVID-19 vaccine. Photo: Ben Hasty/MediaNews Group/Reading Eagle via Getty Images

The Biden administration is planning to purchase 500 million more Pfizer-BioNTech coronavirus vaccine doses to donate to the world, officials said in an op-ed Wednesday.

Why it matters: The move represents a big step toward making the U.S. a major global vaccine supplier just as China has ramped up exports of its Sinopharm, Sinovac and CanSino vaccines, which can be stored at normal refrigerator temperatures.

You’ve caught up. Now what?

Sign up for Mike Allen’s daily Axios AM and PM newsletters to get smarter, faster on the news that matters.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!